Predictions for 2019

With 2019 underway, Wasdell’s Managing Director Daniel Tedham weighs in with Pharma Manufacturing about the expectations for the next twelve months and what changes are to come.

“As the demand for personalised medicines rises, smaller volume biotech products are therefore likely to be prevalent across 2019 as breakthroughs for rare and hard to treat conditions are made.” You can read all about it in Pharma Manufacturing here:

Comments are currently closed.